<DOC>
<DOCNO>
EP-0003007
</DOCNO>
<TEXT>
<DATE>
19790711
</DATE>
<IPC-CLASSIFICATIONS>
C07F-9/00 A61K-31/665 A61P-31/00 A61K-31/66 A61P-31/16 A61P-31/12 C07F-9/38 <main>C07F-9/40</main> C07F-9/40 A61P-35/00 
</IPC-CLASSIFICATIONS>
<TITLE>
aliphatic derivatives of phosphonoformic acid, pharmaceutical compositions and methods for combating virus infections.
</TITLE>
<APPLICANT>
astra laekemedel abse  <sep>astra lakemedel aktiebolag<sep>astra läkemedel aktiebolagsträngnäsvägen 44151 85 södertäljese<sep>astra lakemedel aktiebolag<sep>
</APPLICANT>
<INVENTOR>
helgstrand ake john erik<sep>johansson karl nils-gunnar<sep>misiorny alfons<sep>noren jan-olof<sep>stening goran bertil<sep>helgstrand, ake john erik<sep>johansson, karl nils-gunnar<sep>misiorny, alfons<sep>noren, jan-olof<sep>stening, goran bertil<sep>helgstrand, ake john erikbäverstigen 32s-150 23 enhörnase<sep>johansson, karl nils-gunnarbäverstigen 19s-150 23 enhörnase<sep>misiorny, alfonslerbäcksgränd 30s-124 43 bandhagense<sep>norén, jan-olofvarstavägen 77s-140 32 grödingese<sep>stening, göran bertilpuckvägen 8s-151 50 södertäljese<sep>helgstrand, ake john erik<sep>johansson, karl nils-gunnar<sep>misiorny, alfons<sep>noren, jan-olof<sep>stening, goran bertil<sep>helgstrand, ake john erikbäverstigen 32s-150 23 enhörnase<sep>johansson, karl nils-gunnarbäverstigen 19s-150 23 enhörnase<sep>misiorny, alfonslerbäcksgränd 30s-124 43 bandhagense<sep>norén, jan-olofvarstavägen 77s-140 32 grödingese<sep>stening, göran bertilpuckvägen 8s-151 50 södertäljese<sep>
</INVENTOR>
<ABSTRACT>
1.  a pharmaceutical preparation containing as active  ingredient a compound of the formula    wherein r₁ and r₂ are the same or different, and each is  selected from the group consisting of hydrogen, alkyl  groups containing 1-6 carbon atoms; cycloalkyl groups  containing 3-6 carbon atoms; cycloalkyl-alkyl groups containing  4-6 carbon atoms; 1-adamantyl; 2-adamantyl, benzyl;  and phenyl groups of the formula    wherein r₄ and r₅ are the same or different, and each is  selected from the group consisting of hydrogen, halogen,  alkyl having 1, 2, or 3 carbon atoms, alkoxy having 1, 2, or  3 carbon atoms, alkoxycarbonyl having 2-7 carbon atoms  and alkylcarbonyl groups having 2-7 carbon atoms; or r₄  and r₅ together form a straight saturated alkylene chain  having 3 or 4 carbon atoms and being bound to adjacent  positions, i. e.  2,3- or 3,4- in the phenyl ring; and r₃ is selected from the group consisting of hydrogen,  alkyl groups containing 1-8 carbon atoms; cycloalkyl  groups containing 3-8 carbon atoms; cycloalkyl-alkyl  group containing 4-8 carbon atoms; 1-adamantyl; 2-adamantyl;  benzyl; and phenyl groups of the formula    wherein r₄ and r₅ have the meaning given above; provided  that at least one of the groups r₁, r₂ and r₃ is alkyl, cycloalkyl,  or cycloalkyl-alkyl as defined above, or 1-adamantyl,  2-adamantyl, or benzyl; and provided that when r₃ is h,  then one of r₁ and r₂ is alkyl, cycloalkyl, or cycloalkyl-alkyl  as defined above, or 1-adamantyl, 2-adamantyl, or benzyl  and the other of r₁ and r₂ is h; or a physiologically acceptable  salt or an optical isomer thereof; novel compounds  within formula i, methods for their preparation and their  medicinal use.  
</ABSTRACT>
</TEXT>
</DOC>
